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Abstract Buccal cells are an important source of DNA in
epidemiological studies, but little is known about factors
that influence amount and purity of DNA. We assessed
these factors in a self-administered buccal cell collection
procedure, obtained with three cotton swabs. In 2,451
patients DNA yield and in 1,033 patients DNA purity was
assessed. Total DNA yield ranged from 0.08 to 1078.0 lg
(median 54.3 lg; mean 82.2 lg ± SD 92.6). The median
UV 260:280 ratio, was 1.95. Samples from men yielded
significantly more DNA (median 58.7 lg) than those from
women (median 44.2 lg). Diuretic drug users had signifi-
cantly lower purity (median 1.92) compared to other anti-
hypertensive drug users (1.95). One technician obtained
significantly lower DNA yields. Older age was associated
with lower DNA purity. In conclusion, DNA yield from
buccal swabs was higher in men and DNA purity was
associated with age and the use of diuretics.
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Introduction
Epidemiologists are increasingly trying to supplement
observational data with biological material, including DNA.
Blood is the specimen of choice for obtaining genomic
DNA for most large scale epidemiological studies [1, 2].
However, such studies might need alternative sources when
study subjects are reluctant to provide a blood sample or
when only a self-administered collection protocol is logis-
tically or economically feasible. Buccal cell collection
seems to be a good alternative for invasive blood collection.
This buccal cell collection can be performed by a buccal
swab or mouth wash procedure. A few studies compared
these methods in terms of DNA-yield. Most of these studies
found that mouthwash procedures provide more yield and
higher-quality DNA than buccal swab methods [2–4].
Nevertheless, DNA collection with the use of buccal swabs
has many advantages such as light weight postage, cost
effective processing for long-term archiving, and easy
obtain ability from widely dispersed participants, it is
comfortable for the patient and tasteless. Moreover, col-
lecting buccal cells rather than blood may be especially
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appropriate in a pediatric setting. Furthermore buccal swab
methods provide sufficient DNA for polymerase chain
reactions in which only nanogram quantities of DNA are
needed [5, 6]. However, little is known about factors that
influence the amount and purity of DNA, obtained from
buccal cell collection protocols. Knowledge of these factors
is of great importance to optimize the yield of this method.
In blood, predictors of variation in DNA yield are age, daily
smoking status, high-density lipoprotein cholesterol, sys-
tolic blood pressure, triglycerides, history of acute myo-
cardial infarction (MI) and possibly diabetes mellitus [7, 8].
Determinants of DNA yield from whole blood samples may
not be the same as for buccal samples. Results from studies
that focused on determinants of DNA yield in buccal cells
are inconsistent and considered only a few factors while as
far as we know, no study has focused on drug use as a
determinant of DNA yield and no study has assessed
determinants of DNA purity [1, 9, 10]. Therefore, we con-
ducted a study to assess which factors determine the amount
and purity of DNA in a self-administered, non-invasive and
relatively inexpensive buccal cell collection procedure.
Materials and methods
Study design
We designed a case–control study in which we will assess
whether specific genetic polymorphisms modify the effect
of antihypertensive drugs. Within this large pharmacoge-
netic study we conducted a cross-sectional study to perform
determinants of DNA yield and purity [11–13]. Participants
were enrolled from the population-based pharmaco-mor-
bidity record linkage system (PHARMO). PHARMO has
been linking drug dispensing histories from a representative
sample of Dutch community pharmacies to the national
registration of hospital discharges (LMR) as from 1985. In
the PHARMO database, subjects who use antihypertensive
drugs were selected. From this cohort, subjects hospitalized
for MI were included as cases. Controls, without MI, were
matched on age (±1 year), sex and geographical location.
Patients were excluded if they were \18 years of age, if
they were not currently taking at least 1 antihypertensive
medication at the date of hospitalization for the first MI for
cases (last prescription not more than 100 days before index
date; 90 days plus 10 days to account for irregularity of
refills) and the same date for their matched controls or if
their DNA yield was not available.
Procedures
For all patients information about the use of drugs, that
induce hyposalivation as an adverse drug reaction
(anticholinergics ATC code: R03BB, antidepressants ATC
code: N06A, anti-inflammatory and antirheumatic prod-
ucts, non-steroid ATC code: M01A, topical products for
joint and muscular pain ATC code: M02A, benzodiazepine
derivatives ATC code: N05BA, antipsychotics ATC code:
N05A, sympathomimetics ATC code: R01BA, muscle
relaxants peripherally acting agents ATC code: M03), on
the date of DNA collection was obtained from the
PHARMO database [14, 15]. Patients were recruited
through community pharmacies, which participate in
PHARMO. From these pharmacies the patients received a
letter in which the purpose of the study was explained.
They were asked for written informed consent to partici-
pate in this study and to return the informed consent form
and a questionnaire. For all participants explicit informed
consent was asked for collection, storage and genotyping of
the buccal swab material. Information on ethnicity, smok-
ing, hypertension, hypercholesterolemia, diabetes mellitus,
use of alcohol, diets, history of cardiovascular diseases,
family history of cardiovascular diseases, weight and
height was collected through self-administered question-
naires and linked with automated general practice and
laboratory registrations. Approval for this study was
obtained from the Medical Ethics Committee of the Uni-
versity Medical Center Utrecht, The Netherlands.
DNA collection and isolation
Individuals who agreed to participate in the study were
asked to supply a sample of buccal cells. The collection of
buccal swabs was performed by the participants themselves
[14, 15]. They received one page of collection instructions,
three cotton swabs, and three 15 ml tubes containing 2 ml
buffer (1,880 ll STE (100 mM NaCl, 10 mM EDTA,
10 mM Tris), 100 ll 10% SDS and 20 ll of 10 mg/ml
Proteinase K). All participants were instructed to rinse their
mouth with tap water before collection. Subsequently, they
were instructed to rub with the swab along the inside of the
cheek and against their gums for 1 min in the morning,
afternoon and evening. After each rub the cotton swab
should be placed in one of the tubes and then sent back, in a
prepaid return envelope, to the laboratory. Upon arrival, the
Proteinase K concentration was increased to 0.2 mg/ml and
the sample was lysed by incubation at 65C for 2 h. The
cotton swabs were placed in a syringe cover inside a 50 ml
tube and centrifuged at 1,000 rpm for 60 s. The remaining
buffer from the original 15 ml tube was poured into the
50 ml tube. DNA was then purified by adding 0.2 volumes
of potassium acetate and putting the sample on ice for
15 min. The aqueous phase was extracted with 1 volume
chloroform/isoamyl alcohol (24:1) and mixed for 30 min.
After 15 min of centrifuging at 3,000 rpm the aqueous
phase was transferred to a clean 50 ml tube. DNA was
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precipitated by adding two volumes ethanol absolute and
pelleted by centrifugation (3,000 rpm for 10 min). After
washing with 70% ethanol twice, the pellet was dried and
resuspended in TE (200 ll). DNA samples were stored
at -30C.
The yield and purity of the DNA were determined by
spectrophotometry (nanodrop ND-1000) using the ratio of
UV absorbance at 260 and 280 nm. A UV absorbance ratio
of 1.8 \ R \ 2.0 was considered to be good purified DNA.
The UV absorbance ratio measurements were started up
later in time. Laboratory personnel were blinded to patient
characteristics.
We did not know at what time the patient was collecting
the DNA and whether the patient returned the swabs
immediately after the collection to the laboratory. There-
fore, in order to assess the influence of time from swabbing
to extraction on DNA yield and purity, buccal swab sam-
ples from the same person (n = 4) were collected and
stored for 2 weeks, for 1 week, for 1 day and for a few
hours in the collection medium (buffer and enzyme) before
DNA was isolated. For these samples we also performed a
gel electrophoresis analysis.
Statistical analysis
Median regression was used to examine the relationship
between median DNA yield (and DNA purity) and deter-
minants, 95% confidence intervals for regression coeffi-
cients were estimated by inverting a rank test as described
in Koenker [16].
All analyses were performed using R 2.8.1 with library
‘‘quantreg’’.
Results
In 2,451 patients (1,684 male and 767 female) DNA yield
and in 1,033 patients (682 male and 351 female) DNA
purity was assessed. The baseline characteristics are given
in Table 1. There was no difference between the group
from which only DNA yield was estimated and the group
from which also DNA purity was estimated. The mean age
of the participants was 64.5 years (range 28.5–92.5). Total
DNA yield ranged from 0.08 to 1,078.0 lg (median
54.3 lg; mean ± SD is 82.2 lg ± 92.6). The median UV
260:280 ratio was 1.95, whereas 59.8% of the samples had
a UV 260:280 ratio between 1.8 and 2.0. No association
was found between DNA yield and DNA purity (data not
shown). The mean time between sending buccal swabs to
the patient and returning of the DNA-samples to the lab-
oratory (=transport time) was 12 days. Samples from men
yielded statistically significantly more DNA (median
58.7 lg) than those from women (median 44.2 lg; median
difference 15.3 lg; Table 2). DNA purity was the same for
both men and women. With increasing age there was a
trend for decreasing DNA purity. Case–control status did
not influence the DNA amount and DNA purity (Tables 2,
3). Laboratory technician number four obtained a lower
DNA yield than the other three, which was statistically
significant. The number of subjects of non-Whites origin
was too few to assess racial differences in DNA yield and
DNA purity. Neither the use of thiazide diuretics compared
to the use of other antihypertensive drugs nor the use of
other drugs that may induce hyposalivation influenced
DNA yield. Nevertheless, the use of thiazide diuretics was
Table 1 Baseline characteristics
Characteristic N = 2,451 Mean (±SD)
Age (year) 64.5 (10.3)
Gender male (%) 69.0
Yield (median lg) 54.3
UV 260:280 (median) 1.95
Transport time (days) 12.0 (22.3)
Table 2 Median DNA yield (lg) from buccal cell samples
Determinant Number Median DNA
yield [IQR]
Difference
(95% CI)*
Transport time 2,448 54.3 (25.7–100.8) -0.005 (-0.04 to 0.11)
Gender
Female 767 44.2 (20.5–81.2) Reference
Male 1,684 58.7 (29.3–110.9) 15.3 (11.7 to 21.3)
Age (year) 2,451 54.3 (25.6–101.5) 0.4 (-0.04 to 0.36)
Case–control
Control 2,042 54.4 (25.9–100.8) Reference
Case 409 53.4 (24.3–104.8) -0.1 (-5.2 to 6.3)
Laboratory technician
1 1,360 54.2 (26.5–102.4) Reference
2 261 57.7 (31.9–99.0) 5.4 (-2.0 to 10.9)
3 108 63.5 (35.5–100.9) 10.5 (-1.9 to 19.1)
4 712 50.5 (20.2–103.6) -5.3 (-11.4 to -0.50)
Ethnicity
White 2,368 54.0 (25.5–101.1) Reference
Black 14 46.7 (33.7–107.4) 0.8 (-21.8 to 44.3)
Asian 23 63.5 (21.7–116.6) 16.7 (-24.7 to 52.3)
Other 25 57.9 (41.2–101.4) 1.2 (-0.9 to 29.9)
Thiazide diuretic use
No 2,249 54.6 (25.0–103.6) Reference
Yes 178 52.8 (27.5–84.9) -0.3 (-8.0 to 6.2)
Hyposalivation inducing drugs
No 2,093 54.3 (25.9–102.9) Reference
Yes 334 53.3 (21.8–99.0) 0.2 (-3.5 to 5.9)
* Adjusted for all other determinants
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significantly associated with decreased DNA purity
compared to other antihypertensive drug use (1.92 vs. 1.95,
respectively; Table 3). However, other drugs, inducing
hyposalivation, did not influence DNA purity. For all
analyses adjustment for the other determinants did not
substantially influence the median difference.
Storage time from the swabs in the collection medium
did not influence DNA yield and purity (data not shown).
Furthermore, no difference in degradation was found for
different storage times. In most samples only DNA with a
high molecular weight was present and DNA was hardly
degraded.
All DNA samples were assayed by a PCR method for
genotyping of polymorphisms in the a-adducin, angioten-
sin converting enzyme, angiotensinogen, angiotensin II
type 1 receptor, G-protein b3 and endothelial nitric oxide
synthase genes [17].
Discussion
In this study, we found that DNA yield of buccal cell
samples was higher in men than in women. DNA purity
was associated with age and the use of thiazide diuretics.
In one study it was found that men from one study group
had a higher median amount of human specific DNA
compared to women who participated in another study
group using a mouthwash protocol [9]. In another study
which also investigated the feasibility of collecting buccal
cells with a mouthwash procedure, mean DNA yield was
also found to be lower in women than in men [1]. On the
other hand one study did not find a significantly difference
in the average amount of DNA between men and women
[10]. The difference in the amount of DNA between men
and women may reflect less vigorous scraping among
women. However, in a study comparing 30 s rubbing the
cheeks against the teeth versus no rubbing prior to a
cytobrush collection did not find a difference [18].
We did not find an association between age and DNA
yield. One study found a positive correlation between age
and quantity of DNA in buccal cell samples and in another
study variation by age in buccal cell yield was suggested
[9, 10]. In blood increasing age led to a significant reduc-
tion in DNA yield [8]. This decline in DNA yield may
represent the known decline in total leukocyte and lym-
phocyte count that occurs between birth and adulthood and
is not an explanation for a decrease in buccal cell DNA
yield. Dry mouth as a symptom of getting older is also not
Table 3 Median DNA purity
from buccal cell samples
* Adjusted for all other
determinants
Determinant Number Median
DNA purity
Differences
(95% CI)*
Transport time 1,032 1.95 (1.87–2.01) 0.00 (-0.002 to 0.0005)
Gender
Female 351 1.95 (1.87–2.01) Reference
Male 682 1.94 (1.87–2.01) 0.00 (-0.02 to 0.013)
Age (year) 1,033 1.95 (1.97–2.01) 0.002 (0.001 to 0.003)
Case–control
Control 942 1.94 (1.87–2.01) Reference
Case 91 1.95 (1.85–2.01) -0.005 (-0.039 to 0.0030)
Laboratory technician
1 961 1.95 (1.87–2.01) Reference
2 65 1.90 (1.85–1.99) -0.03 (-0.068 to 0.012)
3 4 1.97 (1.87–1.99) X
4 2 2.01 (1.98–2.05) X
Ethnicity
White 999 1.95 (1.87–2.01) Reference
Black 7 1.89 (1.77–1.90) -0.034 (-0.175 to -0.010)
Asian 12 1.97 (1.90–2.01) 0.021 (-0.033 to 0.050)
Other 10 1.90 (1.86–1.95)
Thiazide diuretic use
No 916 1.95 (1.87–2.01) Reference
Yes 116 1.92 (1.85–2.00) -0.030 (-0.056 to -0.007)
Hyposalivation inducing drugs
No 877 1.94 (1.87–2.01) Reference
Yes 155 1.96 (1.86–2.01) 0.001 (-0.021 to 0.025)
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a probable explanation, considering that drugs that induce
hyposalivation did not influence DNA yield.
We could not assess the influence of race on DNA yield
due to a small number of black and Asian subjects. One
other study concluded that mean DNA yield was lower in
Japanese compared with Whites, whereas another study
only suggested variation by ethnicity [1, 9].
DNA yield can vary by laboratory personnel for instance
depending on the routine of the laboratory technician. The
critical step in the protocol is the separation of the water
phase with DNA from the chloroform/isoamyl alcohol
phase. The layer between the phases may not be touched
because that may influence yield and purity. A lower yield
may be associated with a laboratory technician that extracts
less water phase and thereby has smaller risk of touching
the in between layer.
In our study no significant association with transport time
was found while in one study it was stated that holding DNA
mouthwash samples at room temperature and processing
them 10 or 30 days after collection yielded statistically
significantly less DNA [9]. The main difference between the
studies consisted of the storage medium in which the DNA
was transported. In our study participants used cotton swabs
to collect buccal cells and were asked to place them in tubes
containing buffer solution. The composition of the buffer,
including proteinase K, was different from the Scope
mouthwash, which was used in the other study. Storage of the
swabs in tubes with buffer and enzyme for 2 weeks did not
influence DNA yield compared to storage for 1 week, 1 day
or no storage. The small number of samples (N = 4) used to
determine the influence of the storage time is a limitation. On
the other hand the median DNA yield and purity of 85
samples with a transport time longer than 30 days did not
deviate from the samples with a transport time shorter than
30 days, which confirmed the findings with the four samples.
Drugs that cause hyposalivation and dry mouth as an
adverse drug reaction did not influence DNA yield or DNA
purity. On the other hand lower DNA purity among diuretic
drug users compared to other antihypertensive drug users
was found while diuretic drugs also may induce hyposali-
vation. It is unclear by which mechanism diuretic drugs can
influence DNA purity. In our study all patients are taking
antihypertensive drugs. However, DNA yield is probably
not influenced by taking antihypertensive drugs, as the use
of diuretic drugs, which are most likely to influence DNA
yield because of their adverse drug reaction, did not modify
DNA yield. For pharmacogenetic studies it is good to know
that antihypertensive drugs and drugs inducing hyposali-
vation do not influence DNA yield. We used the PHARMO
database to assess antihypertensive drug use. The
PHARMO data have been validated on several occasions
with regard to hospital discharge data [19, 20] and drug
exposure [21, 22].
Most studies investigated the DNA purity by gel
electrophoresis or PCR analysis. Only one study estimated
the average DNA ratio 260:280 which was significantly
higher in swab samples than in mouthwash samples.
However, they did not study other determinants [2].
Two small studies mentioned the possibility of a higher
DNA yield when swabbing multiple times [23, 24]. In our
study the participants were asked to do the collection
procedure three times which resulted in DNA yields high
enough for genotyping. Collecting more than three samples
will probably result in lower response rates because of
unwillingness to swab repeatedly over several time points.
In our study a wide range of DNA yields was found. A
possible explanation for this wide range might be the
contamination with bacterial DNA. We could not differ-
entiate between bacterial and human DNA. However, the
isolated DNA was PCRable and genotyping of the samples
was successful, indicating the total amount of human DNA
is sufficient and also indicating the DNA samples were not
too degraded. The findings of the gel electrophoresis sup-
port this non-degradation. In our study a lot of genotyping
can be done with the remaining DNA. However, buccal
cell samples provide substantially smaller quantities of
DNA than do whole blood specimens. The whole-genome
amplification (WGA) might be an attractive solution to this
problem [25, 26]. The way we have isolated DNA is time-
consuming. Therefore we recommend to use DNA self-
collection kits which simplify DNA purification, for
example oragene DNA self collection kits from DNA
genotek.
In conclusion, gender, age, diuretic drug use and labo-
ratory personnel must be taken into account when col-
lecting buccal cell samples. To get high DNA yield and
high DNA purity, it is necessary to have good qualified
laboratory personnel. More over, one must consider if
women need to collect an extra buccal swab.
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